124 related articles for article (PubMed ID: 36695325)
1. The association of serum immunoglobulin and complement levels and liver fibrosis and inflammation stage in patients with chronic hepatitis B.
Lian M; Wang Q; Chen S; Yang Y; Hong G
J Viral Hepat; 2023 May; 30(5):437-447. PubMed ID: 36695325
[TBL] [Abstract][Full Text] [Related]
2. Immunoglobulin and complement depositions in the liver of chronic hepatitis patients.
Vasei M; Monabbati A; Alizadeh-Naeeni M; Houshmand S; Azarpira N; Lankarani KB; Mosallaee M; Taghavi Sa; Geramizadeh B; Saberi-Firouzi M; Imaniyeh MH
Hepatogastroenterology; 2008; 55(84):1066-70. PubMed ID: 18705329
[TBL] [Abstract][Full Text] [Related]
3. [Relation between HBsAg levels during the immune clearance phase of hepatitis B virus infection and liver pathological stages of chronic hepatitis B].
Zeng DW; Dong J; Chen LH; Zhu YY; Chen J; Zheng Q; Liu YR; Jiang JJ
Zhonghua Gan Zang Bing Za Zhi; 2012 Oct; 20(10):746-50. PubMed ID: 23207334
[TBL] [Abstract][Full Text] [Related]
4. [Association between serum vitamin D level and immune imbalance in advanced schistosomiasis patients with liver fibrosis].
Zhou LY; Zhang LF; Wu YM; Han SY
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2021 Feb; 33(1):22-27. PubMed ID: 33660470
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin A and complement C4 are involved in the progression of liver fibrosis in patients with chronic hepatitis B.
Zhang X; Wan Z; Lin M; Li Y; Wu X; Jiang J; Lin S; Chi X
Int Immunopharmacol; 2023 Sep; 122():110604. PubMed ID: 37451022
[TBL] [Abstract][Full Text] [Related]
6. [Predictive value of liver pathologic changes in determining the effectiveness of entecavir treatment for chronic hepatitis B-An analysis of 1 366 cases].
Sun MM; Zhang W; Chen G; An Y; Wang YQ; Shang QH
Zhonghua Yi Xue Za Zhi; 2017 Apr; 97(15):1160-1164. PubMed ID: 28427123
[No Abstract] [Full Text] [Related]
7. Complement C3 Facilitates Stratification of Stages of Chronic Hepatitis B and Signifies Development of Acute-on-Chronic Liver Failure in Acute Decompensated Cirrhosis.
Chen C; Yuan Z; Li W; Fei L; Ji L; Huang Q; Zhang S; Chen L
Adv Ther; 2023 Mar; 40(3):1171-1186. PubMed ID: 36652176
[TBL] [Abstract][Full Text] [Related]
8. Plasma Complement 3 and Complement 4 Are Promising Biomarkers for Distinguishing NMOSD From MOGAD and Are Associated With the Blood-Brain-Barrier Disruption in NMOSD.
Lin L; Wu Y; Hang H; Lu J; Ding Y
Front Immunol; 2022; 13():853891. PubMed ID: 35898513
[TBL] [Abstract][Full Text] [Related]
9. A pilot and comparative study between pathological and serological levels of immunoglobulin and complement among three kinds of primary glomerulonephritis.
Dong J; Peng T; Gao J; Jia X; Yan G; Wang Y
BMC Immunol; 2018 Jun; 19(1):18. PubMed ID: 29925312
[TBL] [Abstract][Full Text] [Related]
10. [Liver histological changes in chronic hepatitis B patients with elevated ALT less than 2 x ULN].
Xian JC; Xu HT; He YL; Shen ML; Chen YB; Zhang LX; Xiao L; Li Y; Han LB; Li H; Lu LG
Zhonghua Gan Zang Bing Za Zhi; 2011 Jun; 19(6):431-5. PubMed ID: 22053373
[TBL] [Abstract][Full Text] [Related]
11. Serum ceruloplasmin levels correlate negatively with liver fibrosis in males with chronic hepatitis B: a new noninvasive model for predicting liver fibrosis in HBV-related liver disease.
Zeng DW; Liu YR; Zhang JM; Zhu YY; Lin S; You J; Li YB; Chen J; Zheng Q; Jiang JJ; Dong J
PLoS One; 2013; 8(10):e77942. PubMed ID: 24282481
[TBL] [Abstract][Full Text] [Related]
12. Plateletcrit as a potential index for predicting liver fibrosis in chronic hepatitis B.
Wang J; Xia J; Yan X; Yang Y; Wei J; Xiong Y; Wu W; Liu Y; Chen Y; Jia B; Chen Z; Zhang Z; Ding W; Huang R; Wu C
J Viral Hepat; 2020 Jun; 27(6):602-609. PubMed ID: 31981279
[TBL] [Abstract][Full Text] [Related]
13. [The relationship between serum HBsAg levels and liver inflammation and fibrosis in patients with chronic hepatitis B].
Zhong LH; Jiang YM; Lou GQ; Yu XL; Liu H; Guo JC; Zhu MF; Xun YH
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Apr; 27(2):92-4. PubMed ID: 24044209
[TBL] [Abstract][Full Text] [Related]
14. Serum liver fibrosis markers discriminate significant liver inflammation in chronic hepatitis B patients with normal or near-normal alanine aminotransferase.
Liao Y; Gong J; Zhou W; Dong H; Liang J; Luo M; Hu B
J Med Virol; 2019 Apr; 91(4):642-649. PubMed ID: 30537157
[TBL] [Abstract][Full Text] [Related]
15. Serum complement C4 in chronic hepatitis C: correlation with histopathologic findings and disease activity.
Buğdaci MS; Karaca C; Alkim C; Kesıcı B; Bayraktar B; Sökmen M
Turk J Gastroenterol; 2012 Feb; 23(1):33-7. PubMed ID: 22505377
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic efficacy of FibroScan for liver inflammation in patients with chronic hepatitis B: a single-center study with 1185 liver biopsies as controls.
Jiang K; Zhang L; Li J; Hu H; Huang Q; Qiu T; Mo X; Ren J; Guo W; Tao Y; Cui H; Zuo Y; Chen X; Xie Y; Li Y; Liang H; Liu Z; Xie L; Mao R; Jiang Q; Huang K
BMC Gastroenterol; 2022 Jan; 22(1):37. PubMed ID: 35090390
[TBL] [Abstract][Full Text] [Related]
17. Alpha-fetoprotein level as a biomarker of liver fibrosis status: a cross-sectional study of 619 consecutive patients with chronic hepatitis B.
Liu YR; Lin BB; Zeng DW; Zhu YY; Chen J; Zheng Q; Dong J; Jiang JJ
BMC Gastroenterol; 2014 Aug; 14():145. PubMed ID: 25128299
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of liver pathological characteristics and exploration of noninvasive markers of liver fibrosis in children with chronic hepatitis B].
Liang CF; Chang YN; Peng XR; He Y; Chen M; Peng ML; Hu P; Ren H; Xu HM
Zhonghua Gan Zang Bing Za Zhi; 2021 Jun; 29(6):551-557. PubMed ID: 34225430
[No Abstract] [Full Text] [Related]
19. The Easy Liver Fibrosis Test (eLIFT) for predicting advanced liver fibrosis in patients with chronic hepatitis B.
Wang J; Chen Z; Yan X; Yang Y; Liu Y; Chen Y; Jia B; Xia J; Xiong Y; Zhang Z; Ding W; Huang R; Wu C
Discov Med; 2019 Sep; 28(153):149-158. PubMed ID: 31926586
[TBL] [Abstract][Full Text] [Related]
20. Ceruloplasmin, a reliable marker of fibrosis in chronic hepatitis B virus patients with normal or minimally raised alanine aminotransferase.
Zeng DW; Dong J; Jiang JJ; Zhu YY; Liu YR
World J Gastroenterol; 2016 Nov; 22(43):9586-9594. PubMed ID: 27920479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
